BIOMARIN PHARMACEUTICAL INC (BMRN)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About BIOMARIN PHARMACEUTICAL INC
BioMarin Pharmaceutical Inc. is a biotechnology company focused on developing and commercializing therapies for severe rare disorders and other serious medical conditions. Its products serve genetically defined diseases, and the company generated $3.2 billion of revenue in FY2025. BioMarin trades on the NASDAQ under the ticker BMRN.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
BIOMARIN PHARMACEUTICAL INC's Technical Indicators Summary
BMRN is in a strong uptrend supported by rising averages and healthy volume, though oscillators show overbought conditions. ADX indicates a meaningful directional trend while MACD and momentum readings are bullish, and the price trades well above short-, medium- and long-term moving averages. OBV confirms buying pressure and the pivot sits below the market, offering intra-day support; ATR indicates moderate volatility and the upper Bollinger region signals the market is extended. Technical takeaway: Strong Buy — trend, momentum and volume align in favor of continued strength, albeit with overbought signals.
| Indicator | Value |
|---|---|
RSI (14) | 80.32 |
Stochastic %K (14, 3, 3) | 95.42 |
CCI (20) | 226.89 |
WPR (14) | -2.35 |
Momentum (10) | 9.31 |
MFI | 84.57 |
MACD Level (12, 26) | 2.51 |
Bollinger Bands | $54.34 - $69.04 |
ATR (14) | $2.09 (2.95%) |
ADX (14) | 26.89 |
OBV | 21,385,951 |
Classic Pivot Point | $69.63 |
Fibonacci Pivot Point | $69.63 |
Exponential Moving Averages | $57.24 - $65.00(5 indicators) |
Simple Moving Averages | $56.61 - $63.56(5 indicators) |
Get premium market insights delivered directly to your inbox.